This role has been previously suggested by next generation sequencing of high-grade PanINs showing an absence of SMAD4 mutations in precancerous lesions, as well as cancer-specific SMAD4 mutations reported in a paired PanIN/carcinoma analyses27,28. Here, SMAD4 is linked to cancer.